HKPJ Article - Review of Vaccines against Herpes Zoster: the Efficacy, Safety and Impact on Quality of Life of Shingrix® and Zostavax®
HKPharm J Volume 31 (2), May-Aug-2024 (2024-09-23): P.44
CPE points (self-study) could be gained by reading this article and answering the quiz with at least 60% of the answers correct. A certificate of achievement will be issued.
Only one attempt is allowed.
The correct answers will be revealed in the next issue of the HKPJ.
CPE points : 2 points
Submission deadline: 31 December 2024, 23:59
This CPE ctivity has ended.
Date:
2024-10-01 to 2024-12-31
Venue:
On line
Organising Institute:
Hong Kong Pharmaceutical Journal
Related CPE Activities:
